litlas
Log inCreate account

Kenneth E. Thummel

Active 1990–2024

121
Papers
22,364
Citations
85
h-index
121
i10-index

Citations

Citations per year for Kenneth E. Thummel1983: 4 citations1989: 2 citations1990: 1 citations1992: 1 citations1993: 5 citations1994: 13 citations1995: 64 citations1996: 51 citations1997: 101 citations1998: 107 citations1999: 139 citations2000: 144 citations2001: 183 citations2002: 224 citations2003: 296 citations2004: 338 citations2005: 355 citations2006: 337 citations2007: 262 citations2008: 265 citations2009: 247 citations2010: 206 citations2011: 179 citations2012: 179 citations2013: 183 citations2014: 140 citations2015: 119 citations2016: 104 citations2017: 100 citations2018: 93 citations2019: 387 citations2020: 360 citations2021: 374 citations2022: 234 citations2023: 165 citations2024: 341 citations2025: 111 citations1984–1988: no citations, so these years are not shown1991: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,084 citing papers, 33.4% of this breakdownUnited Kingdom: 480 citing papers, 7.7% of this breakdownGermany: 348 citing papers, 5.6% of this breakdownChina: 310 citing papers, 5% of this breakdownJapan: 284 citing papers, 4.5% of this breakdownCanada: 251 citing papers, 4% of this breakdownNetherlands: 233 citing papers, 3.7% of this breakdownItaly: 197 citing papers, 3.2% of this breakdownFrance: 178 citing papers, 2.8% of this breakdownSweden: 169 citing papers, 2.7% of this breakdownSwitzerland: 144 citing papers, 2.3% of this breakdownAustralia: 139 citing papers, 2.2% of this breakdown
0%33.4%Other 22.9%

Institutions

Fields

  • Medicine43.9%
  • Pharmacology, Toxicology and Pharmaceutics39.4%
  • Biochemistry, Genetics and Molecular Biology8.5%
  • Engineering2.1%
  • Computer Science2%
  • Environmental Science0.8%
  • Other3.3%

Topics

  • Pharmacogenetics and Drug Metabolism16.5%
  • Drug Transport and Resistance Mechanisms9.5%
  • Pharmacological Effects and Toxicity Studies4.4%
  • Drug-Induced Hepatotoxicity and Protection3%
  • Computational Drug Discovery Methods2.9%
  • Renal Transplantation Outcomes and Treatments1.8%
  • Other61.9%

Coauthors

All papers

Open in search
  1. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

    Authors: Peter Kuehl, Jiong Zhang, Yvonne Lin, Jatinder K. Lamba, Mahfoud Assem, John D. Schuetz, Paul B. Watkins, Ann K. Daly, Steven Wrighton, Stephen D. Hall, P Maurel, Mary V. Relling, Cynthia Brimer, Kazuto Yasuda, Raman Venkataramanan, Stephen C. Strom, Kenneth E. Thummel, Mark S. Boguski, Erin G. Schuetz - Nature Genetics 2001 cited by 2,161

  2. Development of a microphysiological model of human kidney proximal tubule function

    Authors: Elijah J. Weber, Alenka Chapron, Brian D. Chapron, Jenna L. Voellinger, Kevin A. Lidberg, Catherine K. Yeung, Zhican Wang, Yoshiyuki Yamaura, Dale W. Hailey, Thomas Neumann, Danny D. Shen, Kenneth E. Thummel, Kimberly A. Muczynski, Jonathan Himmelfarb, Edward J. Kelly - Kidney International 2016 cited by 267

  3. Evaluation of Cytochrome P450‐Mediated Cannabinoid‐Drug Interactions in Healthy Adult Participants

    Authors: Sumit Bansal, C. Austin Zamarripa, Tory R. Spindle, Elise M. Weerts, Kenneth E. Thummel, Ryan G. Vandrey, Mary F. Paine, Jashvant D. Unadkat - Clinical Pharmacology & Therapeutics 2023 cited by 62

  4. Genetic contribution to variable human CYP3A-mediated metabolism

    Authors: Jatinder K. Lamba, Yvonne S. Lin, Erin G. Schuetz, Kenneth E. Thummel - Advanced Drug Delivery Reviews 2002 cited by 992

  5. Clinical Pharmacokinetic Assessment of Kratom (Mitragyna speciosa), a Botanical Product with Opioid-like Effects, in Healthy Adult Participants

    Authors: Rakshit S. Tanna, James Nguyen, Deena L. Hadi, Preston K. Manwill, Laura Flores‐Bocanegra, Matthew E. Layton, John R. White, Nadja B. Cech, Nicholas H. Oberlies, Allan E. Rettie, Kenneth E. Thummel, Mary F. Paine - Pharmaceutics 2022 cited by 64

  6. Stargazer: a software tool for calling star alleles from next-generation sequencing data using CYP2D6 as a model

    Authors: Seung‐been Lee, Marsha M. Wheeler, Karynne Patterson, Sean McGee, Rachel Dalton, Erica L. Woodahl, Andrea Gaedigk, Kenneth E. Thummel, Deborah A. Nickerson - Genetics in Medicine 2018 cited by 151

  7. CYP3A4 mutation causes vitamin D–dependent rickets type 3

    Authors: Jeffrey D. Roizen, Dong Li, Lauren O’Lear, M K Javaid, Nicholas J Shaw, Peter R. Ebeling, Hanh H. Nguyen, Christine Rodda, Kenneth E. Thummel, Tom D. Thacher, Håkon Håkonarson, Michael A. Levine - Journal of Clinical Investigation 2018 cited by 118

  8. Cyp2e1 Activity Before and After Weight Loss in Morbidly Obese Subjects With Nonalcoholic Fatty Liver Disease

    Authors: Maurice G. Emery, Jeannine M. Fisher, Jenny Chien, Evan D. Kharasch, Patchen Dellinger, Kris V. Kowdley, Kenneth E. Thummel - Hepatology 2003 cited by 176

  9. Interindividual Variability in Cytochrome P450–Mediated Drug Metabolism

    Authors: T. S. Tracy, Amarjit S. Chaudhry, Bhagwat Prasad, Kenneth E. Thummel, Erin G. Schuetz, Xiao‐bo Zhong, Yin-Chun Tien, Hyunyoung Jeong, Xian Pan, Laura M. Shireman, Jessica Tay-Sontheimer, Yvonne S Lin - Drug Metabolism and Disposition 2015 cited by 175

  10. Drug Metabolism and Transport During Pregnancy: How Does Drug Disposition Change during Pregnancy and What Are the Mechanisms that Cause Such Changes?

    Authors: Nina Isoherranen, Kenneth E. Thummel - Drug Metabolism and Disposition 2013 cited by 208

  11. Interplay between vitamin D and the drug metabolizing enzyme CYP3A4

    Authors: Zhican Wang, Erin G. Schuetz, Yang Xu, Kenneth E. Thummel - The Journal of Steroid Biochemistry and Molecular Biology 2012 cited by 123

  12. Calling Star Alleles With Stargazer in 28 Pharmacogenes With Whole Genome Sequences

    Authors: Seung‐been Lee, Marsha M. Wheeler, Kenneth E. Thummel, Deborah A. Nickerson - Clinical Pharmacology & Therapeutics 2019 cited by 92

  13. Assessing Transporter‐Mediated Natural Product‐Drug Interactions Via In vitro‐In Vivo Extrapolation: Clinical Evaluation With a Probe Cocktail

    Authors: James Nguyen, Dandan Tian, Rakshit S. Tanna, Deena L. Hadi, Sumit Bansal, Justina C. Calamia, Christopher M. Arian, Laura M. Shireman, Bálint Molnár, Miklós Horváth, Joshua J. Kellogg, Matthew E. Layton, John R. White, Nadja B. Cech, Richard D. Boyce, Jashvant D. Unadkat, Kenneth E. Thummel, Mary F. Paine - Clinical Pharmacology & Therapeutics 2020 cited by 39

  14. Clinical Assessment of the Drug Interaction Potential of the Psychotropic Natural Product Kratom

    Authors: Rakshit S. Tanna, James Nguyen, Deena L. Hadi, Matthew E. Layton, John R. White, Nadja B. Cech, Nicholas H. Oberlies, Allan E. Rettie, Kenneth E. Thummel, Mary F. Paine - Clinical Pharmacology & Therapeutics 2023 cited by 27

  15. Interpreting Tacrolimus Concentrations During Pregnancy and Postpartum

    Authors: Mary F. Hébert, Songmao Zheng, Karen Hays, Danny D. Shen, Connie L. Davis, Jason G. Umans, Menachem Miodovnik, Kenneth E. Thummel, Thomas R. Easterling - Transplantation 2012 cited by 144

  16. CYP3A4 Induction by Rifampin: An Alternative Pathway for Vitamin D Inactivation in Patients With CYP24A1 Mutations

    Authors: Colin P. Hawkes, Dong Li, Håkon Håkonarson, Kevin Meyers, Kenneth E. Thummel, Michael A. Levine - The Journal of Clinical Endocrinology & Metabolism 2017 cited by 100

  17. Translating Kratom-Drug Interactions: From Bedside to Bench and Back

    Authors: Rakshit S. Tanna, Nadja B. Cech, Nicholas H. Oberlies, Allan E. Rettie, Kenneth E. Thummel, Mary F. Paine - Drug Metabolism and Disposition 2023 cited by 24

  18. New Era in Drug Interaction Evaluation: US Food and Drug Administration Update on CYP Enzymes, Transporters, and the Guidance Process

    Authors: Shiew‐Mei Huang, John M. Strong, Lei Zhang, Kellie S. Reynolds, Srikanth C. Nallani, Robert Temple, Sophia Abraham, Sayed Al Habet, Raman Baweja, Gilbert J. Burckart, Sang M. Chung, Philip M. Colangelo, David M. Frucht, Martin D. Green, Paul Hepp, Elena Karnaukhova, Hee Gyeong Ko, Jang-ik Lee, Patrick Marroum, Janet M. Norden, Wei Qiu, Atiqur Rahman, Solomon Sobel, Toni Stifano, Kenneth E. Thummel, Xiaoxiong Wei, Sally Usdin Yasuda, Jenny Zheng, Hong Zhao, Lawrence J. Lesko - The Journal of Clinical Pharmacology 2008 cited by 400

  19. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing

    Authors: Kelly A. Birdwell, Brian S. Decker, Julia M. Barbarino, Josh F. Peterson, C. Michael Stein, Wolfgang Sadée, Daqing Wang, Alexander A. Vinks, Yijing He, Jesse J. Swen, J. Steven Leeder, RHN van Schaik, Kenneth E. Thummel, Teri E. Klein, Kelly E. Caudle, Iain MacPhee - 2015 cited by 88

  20. Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism*

    Authors: Kenneth E. Thummel, Diarmuid O’Shea, Mary F. Paine, Danny D. Shen, Kent L. Kunze, James D. Perkins, G. Wilkinson - Clinical Pharmacology & Therapeutics 1996 cited by 619

  21. Transcriptional Control of Intestinal Cytochrome P-4503A by 1α,25-Dihydroxy Vitamin D3

    Authors: Kenneth E. Thummel, Cynthia Brimer, Kazuto Yasuda, Jaideep V. Thottassery, Tauri Senn, Yvonne Lin, Hitoshi Ishizuka, Evan D. Kharasch, John D. Schuetz, Erin G. Schuetz - Molecular Pharmacology 2001 cited by 324

  22. ROLE OF ITRACONAZOLE METABOLITES IN CYP3A4 INHIBITION

    Authors: Nina Isoherranen, Kent L. Kunze, Kyle E. Allen, Wendel L. Nelson, Kenneth E. Thummel - Drug Metabolism and Disposition 2004 cited by 275

  23. Effects of chronic kidney disease and uremia on hepatic drug metabolism and transport

    Authors: Catherine K. Yeung, Danny D. Shen, Kenneth E. Thummel, Jonathan Himmelfarb - Kidney International 2013 cited by 213

  24. An Inducible Cytochrome P450 3A4-Dependent Vitamin D Catabolic Pathway

    Authors: Zhican Wang, Yvonne S. Lin, Xi Zheng, Tauri Senn, Takanori Hashizume, Michele Scian, Leslie J. Dickmann, Sidney D. Nelson, Thomas A. Baillie, Mary F. Hébert, David K. Blough, Connie L. Davis, Kenneth E. Thummel - Molecular Pharmacology 2011 cited by 114